Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 3/2015

01-03-2015 | Original Article - Cancer Research

Ezrin-expressing lung adenocarcinoma cells and podoplanin-positive fibroblasts form a malignant microenvironment

Authors: Shigeki Suzuki, Genichiro Ishii, Rie Matsuwaki, Shinya Neri, Hiroko Hashimoto, Chisako Yamauchi, Keiju Aokage, Tomoyuki Hishida, Junji Yoshida, Mitsutomo Kohno, Kanji Nagai, Atsushi Ochiai

Published in: Journal of Cancer Research and Clinical Oncology | Issue 3/2015

Login to get access

Abstract

Purpose

Cancer cells and cancer-associated fibroblasts (CAFs) together create the tumor microenvironment, which affects malignant behavior. Lung adenocarcinomas with CAFs expressing podoplanin (PDPN) are clinically aggressive, but the molecular mechanism underlying this phenomenon has not been established. So we identified the characteristic immunophenotype of lung adenocarcinoma cells coexisting with PDPN-expressing CAFs (PDPN-CAFs) and examined how it relates to an aggressive clinicopathological outcome.

Methods

We analyzed the clinicopathological characteristics of 119 adenocarcinomas with a uniform size (2–3 cm). The expression levels of ten invasiveness-related proteins which related to cell adhesion and invasiveness, such as Ezrin, were examined in cancer cells from PDPN-CAFs (+) cases and from PDPN-CAFs (−) cases (n = 20 each). To examine the functional importance of the identified protein on the invasion phenotype, we performed wound healing and a Matrigel invasion assay using shRNA-knockdown lung adenocarcinoma cells (PC-9).

Results

The PDPN-CAFs (+) cases had significantly higher rates of node metastasis (p < 0.01) and vascular invasion (p < 0.01). The cancer cells from the PDPN-CAFs (+) cases also had a significantly higher staining score for Ezrin (p < 0.01) than those from the PDPN-CAFs (−) cases. The migration and invasion activities of the shEzrin-induced PC-9 cells were significantly lower than those of the control cells.

Conclusions

Our results indicated that within a tumor microenvironment composed of PDPN-CAFs, increased Ezrin expression in cancer cells might play a key role in the invasiveness of lung adenocarcinoma.
Appendix
Available only for authorised users
Literature
go back to reference Asamura H et al (2008) A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 3:46–52CrossRefPubMed Asamura H et al (2008) A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 3:46–52CrossRefPubMed
go back to reference Bretscher A, Edwards K, Fehon RG (2002) ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3:586–599CrossRefPubMed Bretscher A, Edwards K, Fehon RG (2002) ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 3:586–599CrossRefPubMed
go back to reference Chen QY, Xu W, Jiao DM, Wu LJ, Song J, Yan J, Shi JG (2013) Silence of ezrin modifies migration and actin cytoskeleton rearrangements and enhances chemosensitivity of lung cancer cells in vitro. Mol Cell Biochem 377:207–218CrossRefPubMed Chen QY, Xu W, Jiao DM, Wu LJ, Song J, Yan J, Shi JG (2013) Silence of ezrin modifies migration and actin cytoskeleton rearrangements and enhances chemosensitivity of lung cancer cells in vitro. Mol Cell Biochem 377:207–218CrossRefPubMed
go back to reference Cui Y, Li T, Zhang D, Han J (2010) Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma. Cancer Invest 28:242–247CrossRefPubMed Cui Y, Li T, Zhang D, Han J (2010) Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma. Cancer Invest 28:242–247CrossRefPubMed
go back to reference Devesa SS, Bray F, Vizcaino AP, Parkin DM (2005) International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 117:294–299CrossRefPubMed Devesa SS, Bray F, Vizcaino AP, Parkin DM (2005) International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 117:294–299CrossRefPubMed
go back to reference Di Cristofano C et al (2010) Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell. Mod Pathol 23:1012–1020CrossRefPubMed Di Cristofano C et al (2010) Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell. Mod Pathol 23:1012–1020CrossRefPubMed
go back to reference Gottschling S et al (2013) Mesenchymal stem cells in non-small cell lung cancer—different from others? Insights from comparative molecular and functional analyses. Lung Cancer 80:19–29CrossRefPubMed Gottschling S et al (2013) Mesenchymal stem cells in non-small cell lung cancer—different from others? Insights from comparative molecular and functional analyses. Lung Cancer 80:19–29CrossRefPubMed
go back to reference Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, Okumura K (2001) Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91:964–971CrossRefPubMed Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, Okumura K (2001) Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91:964–971CrossRefPubMed
go back to reference Hirao M et al (1996) Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol 135:37–51CrossRefPubMed Hirao M et al (1996) Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol 135:37–51CrossRefPubMed
go back to reference Hofheinz RD et al (2003) Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie 26:44–48CrossRefPubMed Hofheinz RD et al (2003) Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie 26:44–48CrossRefPubMed
go back to reference Hoshino A et al (2011) Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression. Cancer Res 71:4769–4779CrossRefPubMed Hoshino A et al (2011) Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression. Cancer Res 71:4769–4779CrossRefPubMed
go back to reference Ishii G et al (2005) In vivo and in vitro characterization of human fibroblasts recruited selectively into human cancer stroma. Int J Cancer 117:212–220CrossRefPubMed Ishii G et al (2005) In vivo and in vitro characterization of human fibroblasts recruited selectively into human cancer stroma. Int J Cancer 117:212–220CrossRefPubMed
go back to reference Ito TK, Ishii G, Chiba H, Ochiai A (2007) The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene 26:7194–7203CrossRefPubMed Ito TK, Ishii G, Chiba H, Ochiai A (2007) The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene 26:7194–7203CrossRefPubMed
go back to reference Ito M, Ishii G, Nagai K, Maeda R, Nakano Y, Ochiai A (2012a) Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma. Chest 142:151–158CrossRefPubMed Ito M, Ishii G, Nagai K, Maeda R, Nakano Y, Ochiai A (2012a) Prognostic impact of cancer-associated stromal cells in patients with stage I lung adenocarcinoma. Chest 142:151–158CrossRefPubMed
go back to reference Ito S et al (2012b) Tumor promoting effect of podoplanin-positive fibroblasts is mediated by enhanced RhoA activity. Biochem Biophys Res Commun 422:194–199CrossRefPubMed Ito S et al (2012b) Tumor promoting effect of podoplanin-positive fibroblasts is mediated by enhanced RhoA activity. Biochem Biophys Res Commun 422:194–199CrossRefPubMed
go back to reference Karmakar S, Das C (2004) Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts. J Reprod Immunol 64:9–29CrossRefPubMed Karmakar S, Das C (2004) Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts. J Reprod Immunol 64:9–29CrossRefPubMed
go back to reference Kawase A et al (2008) Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int J Cancer 123:1053–1059CrossRefPubMed Kawase A et al (2008) Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int J Cancer 123:1053–1059CrossRefPubMed
go back to reference Kraman M et al (2010) Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 330:827–830CrossRefPubMed Kraman M et al (2010) Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 330:827–830CrossRefPubMed
go back to reference Li Q et al (2012) Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells. Tumour Biol 33:1493–1504CrossRefPubMed Li Q et al (2012) Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells. Tumour Biol 33:1493–1504CrossRefPubMed
go back to reference Louvet-Vallee S (2000) ERM proteins: from cellular architecture to cell signaling. Biol Cell 92:305–316CrossRefPubMed Louvet-Vallee S (2000) ERM proteins: from cellular architecture to cell signaling. Biol Cell 92:305–316CrossRefPubMed
go back to reference Ma L, Liu YP, Zhang XH, Geng CZ, Li ZH (2013) Relationship of RhoA signaling activity with ezrin expression and its significance in the prognosis for breast cancer patients. Chin Med J (Engl) 126:242–247 Ma L, Liu YP, Zhang XH, Geng CZ, Li ZH (2013) Relationship of RhoA signaling activity with ezrin expression and its significance in the prognosis for breast cancer patients. Chin Med J (Engl) 126:242–247
go back to reference Maeda M, Matsui T, Imamura M, Tsukita S, Tsukita S (1999) Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins. Oncogene 18:4788–4797CrossRefPubMed Maeda M, Matsui T, Imamura M, Tsukita S, Tsukita S (1999) Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins. Oncogene 18:4788–4797CrossRefPubMed
go back to reference McClatchey AI (2003) Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer 3:877–883CrossRefPubMed McClatchey AI (2003) Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer 3:877–883CrossRefPubMed
go back to reference Ohta M et al (2013) Positive and negative regulation of podoplanin expression by TGF-beta and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines. Oral Oncol 49:20–26CrossRefPubMed Ohta M et al (2013) Positive and negative regulation of podoplanin expression by TGF-beta and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines. Oral Oncol 49:20–26CrossRefPubMed
go back to reference Okusa Y, Ichikura T, Mochizuki H (1999) Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma. Cancer 85:1033–1038CrossRefPubMed Okusa Y, Ichikura T, Mochizuki H (1999) Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma. Cancer 85:1033–1038CrossRefPubMed
go back to reference Pujuguet P, Del Maestro L, Gautreau A, Louvard D, Arpin M (2003) Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell 14:2181–2191CrossRefPubMedCentralPubMed Pujuguet P, Del Maestro L, Gautreau A, Louvard D, Arpin M (2003) Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell 14:2181–2191CrossRefPubMedCentralPubMed
go back to reference Scott AM et al (2003) A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res 9:1639–1647PubMed Scott AM et al (2003) A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res 9:1639–1647PubMed
go back to reference Suzuki H, Kato Y, Kaneko MK, Okita Y, Narimatsu H, Kato M (2008) Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma. FEBS Lett 582:341–345CrossRefPubMed Suzuki H, Kato Y, Kaneko MK, Okita Y, Narimatsu H, Kato M (2008) Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma. FEBS Lett 582:341–345CrossRefPubMed
go back to reference Takahashi K, Sasaki T, Mammoto A, Takaishi K, Kameyama T, Tsukita S, Takai Y (1997) Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J Biol Chem 272:23371–23375CrossRefPubMed Takahashi K, Sasaki T, Mammoto A, Takaishi K, Kameyama T, Tsukita S, Takai Y (1997) Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J Biol Chem 272:23371–23375CrossRefPubMed
go back to reference Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126:391–401CrossRefPubMed Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S (1994) ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126:391–401CrossRefPubMed
go back to reference Tynninen O, Carpen O, Jaaskelainen J, Paavonen T, Paetau A (2004) Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol 30:472–477CrossRefPubMed Tynninen O, Carpen O, Jaaskelainen J, Paavonen T, Paetau A (2004) Ezrin expression in tissue microarray of primary and recurrent gliomas. Neuropathol Appl Neurobiol 30:472–477CrossRefPubMed
go back to reference Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci 15:166–179CrossRef Xing F, Saidou J, Watabe K (2010) Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci 15:166–179CrossRef
go back to reference Xu Y, Yu Q (2003) E-cadherin negatively regulates CD44-hyaluronan interaction and CD44-mediated tumor invasion and branching morphogenesis. J Biol Chem 278:8661–8668CrossRefPubMed Xu Y, Yu Q (2003) E-cadherin negatively regulates CD44-hyaluronan interaction and CD44-mediated tumor invasion and branching morphogenesis. J Biol Chem 278:8661–8668CrossRefPubMed
go back to reference Yoshizawa A et al (2011) Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 24:653–664CrossRefPubMed Yoshizawa A et al (2011) Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 24:653–664CrossRefPubMed
go back to reference Zhang XQ, Chen GP, Wu T, Yan JP, Zhou JY (2012) Expression and clinical significance of ezrin in non-small-cell lung cancer. Clin Lung Cancer 13:196–204CrossRefPubMed Zhang XQ, Chen GP, Wu T, Yan JP, Zhou JY (2012) Expression and clinical significance of ezrin in non-small-cell lung cancer. Clin Lung Cancer 13:196–204CrossRefPubMed
Metadata
Title
Ezrin-expressing lung adenocarcinoma cells and podoplanin-positive fibroblasts form a malignant microenvironment
Authors
Shigeki Suzuki
Genichiro Ishii
Rie Matsuwaki
Shinya Neri
Hiroko Hashimoto
Chisako Yamauchi
Keiju Aokage
Tomoyuki Hishida
Junji Yoshida
Mitsutomo Kohno
Kanji Nagai
Atsushi Ochiai
Publication date
01-03-2015
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 3/2015
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-014-1851-8

Other articles of this Issue 3/2015

Journal of Cancer Research and Clinical Oncology 3/2015 Go to the issue